Hidetoshi Sumimoto
Impact in
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 26
- Immunotherapy and Immune Responses 18
- Immune Cell Function and Interaction 9
- T-cell and B-cell Immunology 4
-
- RNA Interference and Gene Delivery 7
- Melanoma and MAPK Pathways 4
- Co-authors
- Yutaka Kawakami (21 shared papers)Fumie Imabayashi (1 shared paper)Tomoko Iwata (1 shared paper)Robert G. Roeder (4 shared papers)Makoto Miyagishi (6 shared papers)Hiroyuki Miyoshi (5 shared papers)Kazunari Taira (4 shared papers)M Horikoshi (3 shared papers)
- Journals
- Proceedings of the National Academy of Sciences (4 papers)International Journal of Cancer (3 papers)The Journal of Immunology (3 papers)Gene Therapy (2 papers)Journal of Immunological Methods (2 papers)
- Partner nations
- JapanUnited States
In The Last Decade
Hidetoshi Sumimoto
55 papers receiving 3.2k citations
Hidetoshi Sumimoto's Hit Papers
Peers
Comparison fields: 5 of 101
- Immunology 1.0k
- Oncology 1.1k
- Virology 146
- Molecular Biology 1.6k
- Cancer Research 208
Countries citing papers authored by Hidetoshi Sumimoto
This map shows the geographic impact of Hidetoshi Sumimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidetoshi Sumimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidetoshi Sumimoto more than expected).
Fields of papers citing papers by Hidetoshi Sumimoto
This network shows the impact of papers produced by Hidetoshi Sumimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidetoshi Sumimoto. The network helps show where Hidetoshi Sumimoto may publish in the future.
Co-authors
The 25 scholars most cited alongside Hidetoshi Sumimoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The BRAF–MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells Hit paper breakdown → | 2006 | 555 |
| 2 | 1994 | 264 | |
| 3 | 1992 | 179 | |
| 4 | 2004 | 160 | |
| 5 | 2004 | 145 | |
| 6 | 2016 | 145 | |
| 7 | 1990 | 142 | |
| 8 | 2012 | 128 | |
| 9 | 1990 | 120 | |
| 10 | 2008 | 101 | |
| 11 | 2011 | 95 | |
| 12 | 1991 | 86 | |
| 13 | 1990 | 85 | |
| 14 | 1990 | 81 | |
| 15 | 2011 | 75 | |
| 16 | 2004 | 70 | |
| 17 | 2014 | 59 | |
| 18 | 2001 | 57 | |
| 19 | 2004 | 56 | |
| 20 | 2012 | 54 |
About Hidetoshi Sumimoto
Hidetoshi Sumimoto is a scholar working on Immunology, Molecular Biology, Oncology, Genetics and Pulmonary and Respiratory Medicine, having authored 56 papers that have together received 3.2k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (18 papers), Cancer Immunotherapy and Biomarkers (13 papers), Virus-based gene therapy research (9 papers), Immune Cell Function and Interaction (9 papers), RNA Interference and Gene Delivery (7 papers), CAR-T cell therapy research (6 papers), Melanoma and MAPK Pathways (4 papers) and T-cell and B-cell Immunology (4 papers). The work is most often cited by research in Immunology (1.0k citations), Oncology (1.1k citations), Virology (146 citations), Molecular Biology (1.6k citations) and Cancer Research (208 citations). Hidetoshi Sumimoto has collaborated with scholars based in Japan and United States. Frequent co-authors include Yutaka Kawakami, Fumie Imabayashi, Tomoko Iwata, Robert G. Roeder, Makoto Miyagishi, Hiroyuki Miyoshi, Kazunari Taira, M Horikoshi, S Minakami and Koji Teramoto. Their work appears in journals such as Proceedings of the National Academy of Sciences, International Journal of Cancer, The Journal of Immunology, Gene Therapy and Journal of Immunological Methods.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.